Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.
This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
1. Biomarkers in Cancer Detection and Monitoring of Therapeutics - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iv 5. Copyright - p. Page v 6. Contributors - p. Page vi 7. Preface - p. Page vii 8. List of Illustrations - p. Page viii 9. List of Tables - p. Page ix 10. Chapter One : Oral squamous cell carcinoma - p. Page ix 11. Chapter Two : Genetic predisposition and pathophysiology of oral squamous cell carcinoma - p. Page 70 12. Chapter Three : Molecular biomarkers in gastric cancer - p. Page 100 13. Chapter Four : Recent advancement in molecular markers of pancreatic cancer - p. Page 114 14. Chapter Five : Molecular biomarkers in pancreatic ductal adenocarcinoma - p. Page 143 15. Chapter Six : Biomarkers in endocrine diseases - p. Page 166 16. Chapter Seven : Cancer immunotherapy-associated endocrine complications and treatment strategies - p. Page 197 17. Chapter Eight : Shared and distinct aspects of hematopoietic malignancies such as leukemia and lymphoma - p. Page 215 18. Chapter Nine : Molecular diagnosis, drivers, and treatment modalities for chronic lymphocytic leukemia - p. Page 232 19. Chapter Ten : Myelodysplastic syndrome: A challenging entity - p. Page 246 20. Chapter Eleven : Multiple myeloma - p. Page 270 21. Chapter Twelve : Role of biomarkers in assessing response to immune checkpoint inhibitors in cancer treatment - p. Page 279 22. Chapter Thirteen : Molecular biomarkers in prostate cancer - p. Page 298 23. Chapter Fourteen : Biomarkers in endometrial and cervical cancer - p. Page 310 24. Chapter Fifteen : Skin cancer biology and its biomarkers: Recent trends and prospective - p. Page 319 25. Chapter Sixteen : Genetics of neuronal and glioneuronal cancers - p. Page 330 26. Chapter Seventeen : Therapeutic potential of melatonin in glioblastoma: Current knowledge and future prospects - p. Page 359 27. Chapter Eighteen : Genotype influenced pharmacokinetics of anticancer medicine: A connecting link - p. Page 381 28. Chapter Nineteen : Emergence of metal-based anticancer therapeutics: A promising perspective - p. Page 404 29. Chapter Twenty : Nanoparticles for drug delivery in cancer therapy - p. Page 439 30. Chapter Twenty-One : Near-infrared (NIR) responsive nanomaterial–liposome nanohybrids for cancer photothermal therapy - p. Page 457 31. Chapter Twenty-Two : Anticancer activities of macromolecules of marine origin: Clinical evidence - p. Page 467 32. Chapter Twenty-Three : Therapeutic potential of microalgae and their prospects in targeted delivery in cancer management - p. Page 480 33. Chapter Twenty-Four : Prospects of mangrove-derived phytochemicals in cancer research - p. Page 495 34. Chapter Twenty-Five : Impact of pesticides on immune-endocrine disorders and its relationship to cancer development - p. Page 527 35. Index - p. Page 558
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.
This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
1. Biomarkers in Cancer Detection and Monitoring of Therapeutics - p. Page i 2. Cover - p. Page i 3. Front Matter - p. Page i 4. Table of Contents - p. Page iv 5. Copyright - p. Page v 6. Contributors - p. Page vi 7. Preface - p. Page vii 8. List of Illustrations - p. Page viii 9. List of Tables - p. Page ix 10. Chapter One : Oral squamous cell carcinoma - p. Page ix 11. Chapter Two : Genetic predisposition and pathophysiology of oral squamous cell carcinoma - p. Page 70 12. Chapter Three : Molecular biomarkers in gastric cancer - p. Page 100 13. Chapter Four : Recent advancement in molecular markers of pancreatic cancer - p. Page 114 14. Chapter Five : Molecular biomarkers in pancreatic ductal adenocarcinoma - p. Page 143 15. Chapter Six : Biomarkers in endocrine diseases - p. Page 166 16. Chapter Seven : Cancer immunotherapy-associated endocrine complications and treatment strategies - p. Page 197 17. Chapter Eight : Shared and distinct aspects of hematopoietic malignancies such as leukemia and lymphoma - p. Page 215 18. Chapter Nine : Molecular diagnosis, drivers, and treatment modalities for chronic lymphocytic leukemia - p. Page 232 19. Chapter Ten : Myelodysplastic syndrome: A challenging entity - p. Page 246 20. Chapter Eleven : Multiple myeloma - p. Page 270 21. Chapter Twelve : Role of biomarkers in assessing response to immune checkpoint inhibitors in cancer treatment - p. Page 279 22. Chapter Thirteen : Molecular biomarkers in prostate cancer - p. Page 298 23. Chapter Fourteen : Biomarkers in endometrial and cervical cancer - p. Page 310 24. Chapter Fifteen : Skin cancer biology and its biomarkers: Recent trends and prospective - p. Page 319 25. Chapter Sixteen : Genetics of neuronal and glioneuronal cancers - p. Page 330 26. Chapter Seventeen : Therapeutic potential of melatonin in glioblastoma: Current knowledge and future prospects - p. Page 359 27. Chapter Eighteen : Genotype influenced pharmacokinetics of anticancer medicine: A connecting link - p. Page 381 28. Chapter Nineteen : Emergence of metal-based anticancer therapeutics: A promising perspective - p. Page 404 29. Chapter Twenty : Nanoparticles for drug delivery in cancer therapy - p. Page 439 30. Chapter Twenty-One : Near-infrared (NIR) responsive nanomaterial–liposome nanohybrids for cancer photothermal therapy - p. Page 457 31. Chapter Twenty-Two : Anticancer activities of macromolecules of marine origin: Clinical evidence - p. Page 467 32. Chapter Twenty-Three : Therapeutic potential of microalgae and their prospects in targeted delivery in cancer management - p. Page 480 33. Chapter Twenty-Four : Prospects of mangrove-derived phytochemicals in cancer research - p. Page 495 34. Chapter Twenty-Five : Impact of pesticides on immune-endocrine disorders and its relationship to cancer development - p. Page 527 35. Index - p. Page 558
